Hugo RAS receives FDA 510(k) clearance for urologic surgery

Medtronic/Hugo RAS

Medtronic announced FDA 510(k) clearance for Hugo RAS for urologic procedures. Main competitor to da Vinci; US urology represents ~230,000 eligible procedures annually. First US cases began immediately.

• FDA clearance for prostatectomy, nephrectomy and cystectomy.
• Competes with da Vinci's established market position.
• US urology market: ~230,000 eligible procedures per year.
• Already in commercial use at 35+ countries globally.